Cognitive and speech functioning in head and neck cancer
We collaborate with the Netherlands Quality of Life and Biomedical Cohort study in Head and Neck Cancer (NET-QUBIC) consortium to understand cognitive and speech impairment in patients diagnosed with, and undergoing treatment for, head and neck cancer.
- Assessment of Neurocognitive Impairment and Speech Functioning Before Head and Neck Cancer Treatment
- A valid alternative for in-person language assessments in brain tumor patients: feasibility and validity measures of the new TeleLanguage test
- Lexical selection with competing distractors: Evidence from left temporal lobe lesions
- Lesion evidence for a critical role of left posterior but not frontal areas in alpha-beta power decreases during context-driven word production
- Neuroplasticity of language in left-hemisphere stroke: evidence linking subsecond electrophysiology and structural connections